Related Experiment Video
Updated: Jun 14, 2026
08:27
Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
Genome-wide association studies in pharmacogenomics
1Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, UK. a.k.daly@ncl.ac.uk
Nature Reviews. Genetics
|March 20, 2010
Summary
Genome-wide association studies are identifying genetic factors influencing drug response and adverse reactions. These studies highlight the value of pharmacogenomics in personalized medicine.
Area of Science:
- Pharmacogenomics
- Genetics
- Drug Discovery
Background:
- Genome-wide association (GWA) studies are crucial for understanding pharmacogenomics-related traits.
- Identifying genetic loci affecting drug response or adverse reactions is challenging due to sample size limitations.
Purpose of the Study:
- To review the progress and findings of pharmacogenomics GWA studies.
- To demonstrate the value of GWA studies in identifying clinically relevant genetic associations.
Main Methods:
- Review of published pharmacogenomics GWA studies since 2007.
- Analysis of identified genetic loci and their association with drug response and adverse reactions.
Main Results:
- Several novel and interesting associations between drug responses/reactions and clinically relevant loci have been identified.
- The largest genetic effects have been detected, indicating the potential of GWA studies.
Conclusions:
- Pharmacogenomics GWA studies are valuable for discovering genetic determinants of drug efficacy and safety.
- Continued research in this area promises to advance personalized medicine and improve patient outcomes.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...